MaxCyte (MXCT) Financials: Revenue & Earnings

MXCT price $1.69 +0.15 +9.51%

Ticker
MXCT
Price
$1.69
Change
+0.15 +9.51%
Market cap ?
$174.06M
P/E ?
-4.52
Dividend yield ?
0.00%
Beta ?
1.49
Sector
Healthcare
Industry
Biotechnology

Financials

2016201720182019202020212022202320242025
12269500139850001666700021620700261689003389410044261000412880003862700033026000

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT…

Fair value

MXCT fair value Not meaningful. Price $1.69.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare MXCT

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-10—-0.08—7.39M
2026-08-12-0.08-0.097.27M6.51M
2026-05-12-0.04-0.109.65M7.28M
2026-03-24-0.06-0.087.30M9.08M
2025-11-12-0.12-0.116.83M9.40M
2025-08-06-0.12-0.108.51M10.36M
2025-05-07-0.10-0.1010.39M9.57M
2025-03-11-0.10-0.128.69M9.27M
2024-11-06-0.11-0.138.16M7.67M
2024-08-06-0.09-0.1410.43M7.37M
2024-05-07-0.09-0.1411.34M7.46M
2024-03-12-0.05-0.1015.67M13.09M
2023-11-08-0.11-0.108.00M9.41M
2023-08-09-0.10-0.109.04M10.80M
2023-05-10-0.11-0.118.58M10.79M
2023-03-15-0.05-0.0612.42M8.32M
2022-11-09-0.06-0.0910.64M10.43M
2022-08-10-0.08-0.089.61M9.23M
2022-05-09-0.04-0.0711.59M8.46M
2022-03-22-0.05-0.0510.15M9.56M
2021-11-10-0.03-0.0510.14M12.78M
2021-09-13-0.05-0.057.11M—
2021-07-30-0.09—6.49M—
2020-12-31-0.03—8.51M—
2020-09-30-0.04—6.76M—
2020-06-30-0.05—5.15M—
2020-03-31-0.05—5.74M—
2019-12-31-0.03—6.62M—
2019-09-30-0.03—6.62M—
2019-06-30-0.09—4.19M—
2019-03-31-0.09—4.19M—
2018-12-31-0.04—4.87M—
2018-09-30-0.04—4.87M—
2018-06-30-0.05—3.46M—
2018-03-31-0.05—3.46M—
2017-12-31-0.06—3.89M—
2017-09-30-0.06—3.89M—
2017-06-30-0.05—3.11M—
2017-03-31-0.05—3.11M—
2016-12-31-0.02—3.40M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-06-17Johnston John JosephBuy30.42K——
2026-06-17Johnston John JosephBuy49.58K$1.1356.02K
2026-06-17Hemrajani RekhaBuy30.42K——
2026-06-17Hemrajani RekhaBuy49.58K$1.1356.02K
2026-06-17Erck Stanley CBuy30.42K——
2026-06-17Erck Stanley CBuy49.58K$1.1356.02K
2026-06-17DOUGLAS RICHARDBuy30.42K——
2026-06-17DOUGLAS RICHARDBuy49.58K$1.1356.02K
2026-06-17Collins CynthiaBuy30.42K——
2026-06-17Collins CynthiaBuy49.58K$1.1356.02K
2026-06-17Brooke William WBuy30.42K——
2026-06-17Brooke William WBuy49.58K$1.1356.02K
2026-06-17BALTHROP PATRICK JBuy30.42K——
2026-06-17BALTHROP PATRICK JBuy49.58K$1.1356.02K
2026-06-17Al-Wakeel Yasir B.Buy30.42K——
2026-06-17Al-Wakeel Yasir B.Buy49.58K$1.1356.02K
2026-04-15Ahuja ParmeetBuy187.50K——
2026-03-30Ahuja ParmeetBuy375.00K$0.68253.57K
2026-03-30Ahuja ParmeetOther0——
2026-03-27Masoud MaherBuy600.00K$0.68410.40K
2026-03-27Masoud MaherBuy300.00K——
2026-03-17Swirsky Douglas JSell10.14K$0.818.27K
2025-08-13Swirsky Douglas JBuy50.00K$1.2964.50K
2025-08-13Masoud MaherBuy75.00K$1.37102.92K
2025-08-13Erck Stanley CBuy100.00K$1.37137.22K
2025-08-13DOUGLAS RICHARDBuy80.00K$1.39111.04K
2025-08-13Brooke William WBuy50.00K$1.2964.50K
2025-06-25Hemrajani RekhaSell10.68K$2.0922.38K
2025-06-18Johnston John JosephBuy29.21K——
2025-06-18Johnston John JosephBuy50.79K$2.11107.17K
2025-06-18Hemrajani RekhaBuy50.79K$2.11107.17K
2025-06-18Hemrajani RekhaBuy29.21K——
2025-06-18Erck Stanley CBuy29.21K——
2025-06-18Erck Stanley CBuy50.79K$2.11107.17K
2025-06-18DOUGLAS RICHARDBuy29.21K——
2025-06-18DOUGLAS RICHARDBuy50.79K$2.11107.17K
2025-06-18Collins CynthiaBuy29.21K——
2025-06-18Collins CynthiaBuy50.79K$2.11107.17K
2025-06-18Brooke William WBuy29.21K——
2025-06-18Brooke William WBuy50.79K$2.11107.17K
2025-06-18BALTHROP PATRICK JBuy50.79K$2.11107.17K
2025-06-18BALTHROP PATRICK JBuy29.21K——
2025-06-18Al-Wakeel Yasir B.Buy50.79K$2.11107.17K
2025-06-18Al-Wakeel Yasir B.Buy29.21K——
2025-03-18Soleymannezhad AliSell1.21K$3.183.85K
2025-03-18Sandoval David I.Sell353$3.181.12K
2025-03-18Swirsky Douglas JSell6.94K$3.1822.06K
2025-03-14Soleymannezhad AliBuy138.50K$3.29455.67K
2025-03-14Soleymannezhad AliBuy34.62K——
2025-03-14Sandoval David I.Buy92.50K$3.29304.32K
2025-03-14Sandoval David I.Buy23.12K——
2025-03-14Swirsky Douglas JBuy150.00K$3.29493.50K
2025-03-14Swirsky Douglas JBuy37.50K——
2025-03-14Masoud MaherBuy347.50K$3.291.14M
2025-01-27Johnston John JosephBuy3.00K$2.938.80K
2025-01-27Johnston John JosephSell3.00K$4.6413.93K
2025-01-27Johnston John JosephSell3.00K$2.938.80K
2025-01-13Sandoval David I.Sell4.47K$4.5420.27K
2024-12-26Johnston John JosephBuy3.00K$2.938.80K
2024-12-26Johnston John JosephSell3.00K$4.0112.02K
2024-12-26Johnston John JosephSell3.00K$2.938.80K
2024-12-09Johnston John JosephBuy483$2.931.42K
2024-12-09Johnston John JosephBuy1.12K$1.641.84K
2024-12-09Johnston John JosephBuy891$2.932.61K
2024-12-09Johnston John JosephSell2.50K$3.799.46K
2024-12-09Johnston John JosephSell483$2.931.42K
2024-12-09Johnston John JosephSell1.12K$1.641.84K
2024-12-09Johnston John JosephSell891$2.932.61K
2024-12-06Johnston John JosephBuy505$2.931.48K
2024-12-06Johnston John JosephSell505$3.701.87K
2024-12-06Johnston John JosephSell505$2.931.48K
2024-11-01Erck Stanley CBuy47.69K$0.041.91K
2024-11-01Erck Stanley CSell47.69K$3.72177.40K
2024-11-01Erck Stanley CSell47.69K$0.041.91K
2024-10-28Johnston John JosephBuy3.00K$2.938.78K
2024-10-28Johnston John JosephSell3.00K$3.7211.17K
2024-10-28Johnston John JosephSell3.00K$2.938.78K
2024-10-14Collins CynthiaBuy97.70K$3.87378.09K
2024-10-14Collins CynthiaBuy51.68K——
2024-10-14Collins CynthiaOther0——
2024-10-02Erck Stanley CBuy21.61K$0.04864
2024-10-02Erck Stanley CSell21.61K$3.7180.16K
2024-10-02Erck Stanley CSell21.61K$0.04864
2024-10-01Erck Stanley CBuy26.08K$0.041.04K
2024-10-01Erck Stanley CSell26.08K$3.7898.59K
2024-10-01Erck Stanley CSell26.08K$0.041.04K
2024-09-26Johnston John JosephBuy3.00K$2.938.78K
2024-09-26Johnston John JosephSell3.00K$3.8211.46K
2024-09-26Johnston John JosephSell3.00K$2.938.78K
2024-09-16Soleymannezhad AliBuy10.40K——
2024-09-16Soleymannezhad AliBuy20.80K$4.1285.70K
2024-09-11Soleymannezhad AliSell0——
2024-09-11Soleymannezhad AliSell62.50K$4.31269.38K
2024-09-11Soleymannezhad AliSell275.00K$3.821.05M
2024-09-11Soleymannezhad AliSell25.00K$5.02125.50K
2024-09-04Erck Stanley CBuy29.77K$0.041.19K
2024-09-04Erck Stanley CSell29.77K$3.97118.17K
2024-09-04Erck Stanley CSell29.77K$0.041.19K
2024-09-03Erck Stanley CBuy17.92K$0.04717
2024-09-03Erck Stanley CSell17.92K$4.1073.48K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 125, holders -6 vs prior quarter. Ownership 59.38%.

HolderSharesChangeChange %Value
CAPRICORN FUND MANAGERS LTD8.20M00.00%10.09M
VITRUVIAN PARTNERS LLP5.04M00.00%6.20M
VANGUARD CAPITAL MANAGEMENT LLC4.03M49.47K+1.24%4.96M
MORGAN STANLEY3.69M5.92K+0.16%4.54M
MUDITA ADVISORS LLP3.37M00.00%4.15M
BLACKROCK, INC.3.06M-5.74M-65.21%3.76M
BROOKLANDS FUND MANAGEMENT LTD2.85M658.06K+30.05%3.67M
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A.2.77M00.00%3.41M
CADIAN CAPITAL MANAGEMENT, LP2.20M478.22K+27.76%2.71M
PEAPOD LANE CAPITAL LLC2.13M793.56K+59.57%2.61M
RENAISSANCE TECHNOLOGIES LLC1.91M-82.40K-4.13%2.35M
AQR CAPITAL MANAGEMENT LLC1.88M661.59K+54.18%2.32M
JANE STREET GROUP, LLC1.56M1.54M+7498.83%1.92M
TWO SIGMA INVESTMENTS, LP1.46M854.78K+140.55%1.80M
GEODE CAPITAL MANAGEMENT, LLC1.33M-1.04M-43.84%1.63M
RBF CAPITAL, LLC1.32M1.32MNew1.63M
GOLDMAN SACHS GROUP INC1.24M82.92K+7.15%1.53M
MILLENNIUM MANAGEMENT LLC1.20M1.16M+2698.30%1.48M
NANO CAP NEW MILLENNIUM GROWTH FUND L P1.20M200.00K+20.00%1.48M
MARSHALL WACE, LLP1.01M915.87K+925.94%1.25M
WILLIS INVESTMENT COUNSEL862.76K00.00%1.06M
CITADEL ADVISORS LLC856.32K523.23K+157.08%1.05M
STONEPINE CAPITAL MANAGEMENT, LLC751.61K-253.07K-25.19%924.48K
VANGUARD FIDUCIARY TRUST CO653.20K10.00K+1.55%803.44K
GEORGE KAISER FAMILY FOUNDATION627.54K145.73K+30.25%771.87K

Earnings and financials

MaxCyte, Inc. (MXCT) trades at $1.69, with a market cap of $174.06M and a trailing P/E of -4.52. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
12269500139850001666700021620700261689003389410044261000412880003862700033026000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

MaxCyte (MXCT) Financials: Revenue & Earnings

MXCT$1.69+0.15 +9.51%

$174.06M

Market Cap

-4.52

P/E

—

Forward P/E

—

Score

Price History